Muutke küpsiste eelistusi

Evidence-Based Endocrinology 3rd edition [Pehme köide]

  • Formaat: Paperback / softback, 432 pages, kõrgus x laius: 127x203 mm, kaal: 454 g, 2
  • Ilmumisaeg: 29-May-2012
  • Kirjastus: Lippincott Williams and Wilkins
  • ISBN-10: 145111091X
  • ISBN-13: 9781451110913
Teised raamatud teemal:
  • Pehme köide
  • Hind: 85,60 €*
  • * saadame teile pakkumise kasutatud raamatule, mille hind võib erineda kodulehel olevast hinnast
  • See raamat on trükist otsas, kuid me saadame teile pakkumise kasutatud raamatule.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Lisa soovinimekirja
  • Formaat: Paperback / softback, 432 pages, kõrgus x laius: 127x203 mm, kaal: 454 g, 2
  • Ilmumisaeg: 29-May-2012
  • Kirjastus: Lippincott Williams and Wilkins
  • ISBN-10: 145111091X
  • ISBN-13: 9781451110913
Teised raamatud teemal:
This pocket-sized quick-reference handbook presents evidence-based recommendations for diagnosis and treatment of endocrine disorders. The authors summarize the latest and best clinical studies supporting the practice recommendations and grade each study to indicate the benefits and risks of the therapy and the reliability of the study results. Chapters cover disorders in the major areas of endocrinology--hypothalamic-pituitary, thyroid, adrenal, metabolic bone, reproductive, diabetes, lipid disorders, obesity and nutrition, endocrine malignancies, and genetics.

Arvustused

"This is a concise, easy-to-read, high-yield clinical summary of the major endocrine diseases that highlights clinical studies pertinent to epidemiology, diagnosis, and management. This edition, updated from 2006, also covers imaging technologies currently used in research settings as well as potential upcoming treatment options in clinical trials." "It proficiently highlights landmark and recent clinical studies on diagnostic and therapeutic aspects of management, including upcoming technologies and therapies, and this justifies replacing the previous edition."

- Doody's Book Review (January 2013) Sharon H Chou, MD(University of Chicago Medical Center)

Contributors iv
Preface vii
Acknowledgments viii
Introduction xxi
1 Hypothalamic-Pituitary Disease
1(42)
Gerald Charnogursky
Nicholas Emanuele
Mary Ann Emanuele
Hong Lee
Shanika Samarasinghe
Introduction of the Hypothalamic-Pituitary Axis
1(1)
Pituitary Adenomas
1(4)
Epidemiology and Pathogenesis
1(1)
Diagnosis
2(1)
Treatment
2(1)
Overview
2(1)
Surgery
3(1)
Postoperative Complications
4(1)
Radiation
4(1)
Hypopituitarism
5(9)
Pathophysiology
5(1)
Clinical Findings
6(1)
Secondary Adrenal Insufficiency
6(2)
Central or Secondary Hypothyroidism
8(1)
Secondary Hypogonadism
8(1)
Growth Hormone Deficiency
9(2)
Prolactin Deficiency
11(1)
Treatment
11(1)
Prolactin
11(1)
Pituitary Hormone Excess
11(1)
Thyrotropin Excess
11(1)
Nonfunctional Adenomas and Gonadotropin-Producing Adenomas
12(1)
Prolactin Excess
13(1)
Pituitary Incidentalomas
13(1)
Imaging of the Hypothalamic-Pituitary System
14(2)
Radiologic Imaging Techniques
14(2)
Other Sellar Lesions
16(1)
Disorders of the Prolactin System
16(3)
Pathophysiology
16(1)
Clinical Features
16(1)
Evaluation
17(1)
Management
18(1)
Pregnancy and Hyperprolactinemia
19(1)
Acromegaly
19(1)
Definition
19(1)
Etiology
20(1)
Epidemiology
20(1)
Pathophysiology and Clinical Presentation
20(1)
Diagnosis
20(1)
Treatment
21(1)
Neurosurgery
21(1)
Somatostatin Analogs
21(1)
Radiation Therapy
22(1)
Dopamine Agonists
22(1)
Growth Hormone Receptor Antagonist
22(1)
Diabetes Insipidus
22(2)
Definition
22(1)
Etiology
23(1)
Central Diabetes Insipidus
23(1)
Nephrogenic Diabetes Insipidus
23(1)
Pathophysiology
23(1)
Diagnosis
23(1)
Treatment
24(1)
Central Diabetes Insipidus
24(1)
Nephrogenic Diabetes Insipidus
24(1)
Cushing Disease
24(3)
Etiology and Pathogenesis
24(1)
Clinical Manifestations
25(1)
Laboratory Findings
25(1)
High-Dose Dexamethasone Suppression Test
25(1)
Bilateral Inferior Petrosal Sinus Sampling
25(1)
Treatment
26(1)
Syndrome of Inappropriate Antidiuretic Hormone Secretion
27(3)
Etiology
27(1)
Epidemiology
27(1)
Pathophysiology
27(1)
Diagnosis
27(1)
Clinical Findings
27(1)
Laboratory Findings
28(1)
Treatment
29(1)
Short-Term Therapy
29(1)
Long-Term Therapy
29(1)
Vasopressin Receptor Antagonists
29(1)
References
30(13)
2 Thyroid Disorders
43(38)
M. Regina Castro
Hossein Gharib
Evaluation of Thyroid Function
43(2)
Thyrotropin
43(1)
Free Thyroxine
44(1)
Total Thyroxine and Triiodothyronine
44(1)
Thyroid Autoantibodies
44(1)
Thyroglobulin
45(1)
Thyroid Imaging
45(1)
Ultrasonography
45(1)
Scintigraphy
45(1)
Computed Tomography
46(1)
Radioiodine Uptake
46(1)
131I Whole-Body Scanning
46(1)
18F-Fluorodeoxyglucose Positron Emission Tomography
46(1)
Hyperthyroidism
46(4)
Definition
46(1)
Etiology
47(1)
Epidemiology
47(1)
Pathophysiology
47(1)
Diagnosis
47(1)
Treatment
48(1)
Antithyroid Drugs
48(1)
Antithyroid Drugs plus LT4
48(2)
Radioiodine
50(1)
Surgery
50(1)
β-Blockers
50(1)
Hypothyroidism
50(1)
Definition
50(1)
Etiology
50(1)
Epidemiology and Pathophysiology
51(1)
Diagnosis
51(1)
Treatment
51(1)
Levothyroxine
51(1)
LT4 plus Liothyronine (T3)
51(1)
Thyroid Nodules
51(2)
Etiology
51(1)
Epidemiology
52(1)
Diagnosis
52(1)
Treatment
52(1)
Surgery
52(1)
Suppressive Therapy with Levothyroxine
52(1)
Radioiodine Therapy
53(1)
Percutaneous Ethanol Injection
53(1)
Laser Thermal Ablation (2B)
53(1)
Thyroid Cancer
53(3)
Definition and Classification
53(1)
Epidemiology
54(1)
Diagnosis
54(1)
Fine-Needle Aspiration Biopsy
54(1)
Thyroid Function Tests
54(1)
Tumor Markers
54(1)
Treatment
55(1)
Surgery
55(1)
Radioiodine Remnant Ablation
55(1)
Thyroid Hormone Suppression of TSH
56(1)
Tyrosine Kinase Inhibitors
56(1)
Euthyroid Sick Syndrome
56(1)
Definition and Etiology
56(1)
Pathophysiology
57(1)
Diagnosis
57(1)
Treatment
57(1)
Triiodothyronine Replacement
57(1)
References
57(24)
3 Adrenal Disorders
81(41)
Dana Erickson
Steven A. De Jong
Evaluation of Adrenal Function
81(2)
Evaluation of Glucocorticoid Function
81(1)
Cortisol
81(1)
Adrenocorticotropic Hormone
82(1)
Dynamic Adrenal Tests
82(1)
Evaluation of Mineralocorticoid Function
82(1)
Evaluation of Adrenal Medulla
82(1)
Evaluation of Adrenal Androgen Production and Congenital Adrenal Hyperplasia in Adults
83(1)
Adrenal Imaging
83(3)
Computed Tomography Scanning
83(1)
Magnetic Resonance Imaging
84(1)
Adrenal Cortical Scintigraphy
85(1)
Adrenal Medullary Scintigraphy
85(1)
Positron Emission Tomography
86(1)
Adrenal Vein Sampling
86(1)
Primary Hyperaldosteronism
86(4)
Definition and Etiology
86(1)
Epidemiology
87(1)
Pathophysiology
87(1)
Diagnosis
87(2)
Treatment
89(1)
Cushing Syndrome
90(3)
Etiology and Pathogenesis
90(1)
Clinical Features
90(1)
Evaluation
91(1)
Treatment
92(1)
Adrenal Incidentaloma
93(3)
Definition
93(1)
Etiology
93(1)
Diagnosis
93(1)
Treatment
94(1)
Follow-Up
95(1)
Adrenal Insufficiency
96(4)
Definition
96(1)
Etiology and Epidemiology
96(1)
Pathophysiology
96(1)
Diagnosis
96(1)
Clinical Symptoms
96(2)
Laboratory Diagnosis
98(1)
Imaging Studies
99(1)
Treatment
99(1)
Pheochromocytoma
100(4)
Definition and Etiology
100(1)
Epidemiology
100(1)
Pathophysiology
101(1)
Diagnosis
102(1)
Treatment
103(1)
References
104(18)
4 Metabolic Bone Disorders
Alaleh Mazhari
Zeina Habib
Pauline Camacho
Evaluation of Metabolic Bone Disorders
122(2)
Serum Calcium, Phosphate, and Magnesium
122(1)
Intact Parathyroid Hormone
122(1)
Vitamin D Metabolites
122(1)
Parathyroid Hormone-Related Protein
123(1)
Calcitonin
123(1)
Urinary Calcium Excretion
123(1)
Biochemical Markers of Bone Turnover
123(1)
Bone-Formation Markers
123(1)
Bone-Resorption Markers
123(1)
Clinical Use
124(1)
Bone Imaging
124(3)
Bone Densitometry
125(1)
Scintigraphy
126(1)
Quantitative Computed Tomography
126(1)
Micro-Computed Tomography
126(1)
Quantitative Ultrasound
126(1)
Magnetic Resonance Imaging
127(1)
Bone Biopsy
127(1)
Osteoporosis
127(19)
Definition
127(1)
Epidemiology
127(1)
Pathophysiology
127(1)
Diagnosis
127(1)
Prevention
127(1)
Fracture Risk Assessment
128(1)
Treatment
129(1)
Bisphosphonates
130(4)
Safety Concerns
134(1)
Esophagitis
134(1)
Osteonecrosis of the Jaw
134(1)
Atrial Fibrillation
134(1)
Atypical Femoral Fractures
134(3)
Esophageal Cancer
137(1)
Raloxifene
137(1)
Calcitonin
138(1)
Hormone Replacement Therapy
138(1)
Combination Therapy
138(1)
Teriparatide (PTH 1-34)
138(3)
Safety Concerns
141(3)
Other Therapies
144(1)
Future Therapies
144(2)
Monitoring Therapy
146(1)
Paget Disease of Bone
146(3)
Epidemiology
147(1)
Pathophysiology
147(1)
Diagnosis
147(1)
Treatment
147(1)
Bisphosphonates
147(2)
Calcitonin
149(1)
Other Therapies
149(1)
Primary Hyperparathyroidism
149(4)
Epidemiology
149(1)
Pathogenesis
149(1)
Clinical Presentation
150(1)
Diagnosis
150(1)
Treatment
151(1)
Surgical Management
151(1)
Medical Management
152(1)
Parathyroid Carcinoma
153(1)
Epidemiology
153(1)
Pathogenesis
153(1)
Clinical Manifestations
153(1)
Diagnosis
154(1)
Treatment
154(1)
Hypercalcemia
154(4)
Diagnosis
154(1)
Treatment
155(1)
Address the Primary Cause
155(1)
Decrease Intestinal Absorption
155(1)
Increase Urinary Calcium Excretion
155(1)
Inhibit Bone Resorption
156(1)
Dialysis
157(1)
Hypercalcemie Emergencies
157(1)
Future Therapy
157(1)
Hypocalcemia
158(2)
Diagnosis
158(1)
Treatment
158(1)
Hypocalcemic Emergencies
158(1)
Oral Calcium Supplements
159(1)
Vitamin D
159(1)
Magnesium
160(1)
Parathyroid Hormone
160(1)
Osteomalacia
160(2)
Vitamin D-Dependent Rickets (Type 1 and Type 2)
161(1)
Oncogenic Osteomalacia
161(1)
Hypophosphatemic Rickets
161(1)
Hypophosphatasia
162(1)
Drug-Induced Osteomalacia
162(1)
Vitamin D Deficiency
162(2)
Sources of Vitamin D
162(1)
Prevalence
162(1)
Risk Factors
163(1)
Skeletal Effects
163(1)
Nonskeletal Effects
163(1)
Clinical Presentation
164(1)
Diagnosis
164(1)
Treatment
164(1)
References
164(26)
5 Reproductive Disorders
190(39)
Neil Goodman
Rhoda H. Cobin
Amenorrhea
190(4)
Definition
190(1)
Etiology
190(1)
Epidemiology
190(1)
Pathophysiology
190(1)
Primary Amenorrhea
191(1)
Secondary Amenorrhea
192(1)
Diagnosis
193(1)
Treatment
193(1)
Hyperandrogenism and PCOS
194(3)
Hyperandrogenism
194(3)
PCOS
197(1)
PCOS and Insulin Resistance (Metabolic Syndrome)
197(3)
Diagnosis
198(1)
Treatment
198(2)
Insulin-Sensitizing Drugs
200(1)
Precocious Puberty
200(2)
Definition
200(1)
Pathophysiology
200(1)
Etiology and Diagnosis
200(1)
Treatment
201(1)
Male Hypogonadism
202(4)
Definition
202(1)
Etiology and Diagnosis
203(1)
Congenital Male Hypogonadism
203(1)
Acquired Male Hypogonadism
203(2)
Treatment
205(1)
Treatment Outcomes
206(1)
Infertility
207(2)
Definition
207(1)
Epidemiology
207(1)
Etiology
207(1)
Evaluation
207(1)
Treatment
208(1)
Menopause
209(1)
Definition
209(1)
Diagnosis
209(1)
Treatment
209(1)
References
210(19)
6 Diabetes Mellitus
229(50)
Haitham S. Abu-Lebdeh
Gregg D. Simonson
Type 1 Diabetes Mellitus
229(6)
Definition
229(1)
Etiology
229(1)
Genetics
229(1)
Major Histocompatibility Complex Genes
229(1)
Insulin-Dependent Diabetes Mellitus Genes
230(1)
Rare Forms
230(1)
Epidemiology
230(1)
Pathophysiology
230(1)
Diagnosis
230(1)
Screening
230(1)
Clinical Manifestations
231(1)
Laboratory Findings
231(1)
Prevention
231(1)
Treatment
232(1)
Insulin
232(1)
Insulin Regimens
232(2)
Diet
234(1)
Exercise
234(1)
Blood Glucose Monitoring
234(1)
Transplantation
235(1)
Diet
235(1)
Type 2 Diabetes Mellitus
235(9)
Definition
235(1)
Etiology
235(1)
Risk Factors
235(1)
Epidemiology
236(1)
Pathophysiology of Type 2 Diabetes Mellitus
236(1)
Diagnosis
236(1)
Clinical Manifestations
236(1)
Laboratory Findings
237(1)
Screening
237(1)
Prevention
237(1)
Treatment
238(1)
Weight Reduction and Dietary Restrictions
238(1)
Exercise
238(1)
Oral Drug Therapy
238(3)
Noninsulin Injectable Therapies
241(2)
Combination Therapy
243(1)
Transplantation
244(1)
Diabetic Ketoacidosis
244(3)
Definition
244(1)
Etiology
244(1)
Epidemiology
244(1)
Pathophysiology
244(1)
Diagnosis
245(1)
Laboratory Findings
245(1)
Clinical Manifestations
245(1)
Treatment
245(1)
Fluid Replacement
245(1)
Insulin
245(1)
Bicarbonate
246(1)
Potassium
246(1)
Phosphate
246(1)
Monitoring Therapy
246(1)
Prognosis
246(1)
Hyperosmolar Coma
247(1)
Definition
247(1)
Etiology
247(1)
Pathophysiology
247(1)
Epidemiology
247(1)
Diagnosis
247(1)
Clinical Manifestations
247(1)
Laboratory Findings
247(1)
Treatment
247(1)
Fluids
247(1)
Insulin
248(1)
Electrolytes
248(1)
Hypoglycemia
248(3)
Definition
248(1)
Classification
248(1)
Etiology
248(1)
Pathophysiology
249(1)
Epidemiology
249(1)
Type 1 Diabetes Mellitus
249(1)
Type 2 Diabetes Mellitus
249(1)
Diagnosis
249(1)
Clinical Manifestations
249(1)
Treatment
250(1)
Hypoglycemia Unawareness
250(1)
Complications
250(1)
Cardiovascular Disease
251(8)
Epidemiology
251(1)
Etiology
251(1)
Diagnosis
251(1)
Prevention and Treatment
251(2)
Eye Disease
253(1)
Etiology
253(1)
Pathophysiology
253(1)
Epidemiology
254(1)
Diagnosis
254(1)
Prevention and Treatment
254(1)
Diabetic Neuropathy
255(1)
Classification
255(1)
Pathophysiology
255(1)
Epidemiology
255(1)
Diagnosis
256(1)
Treatment
256(1)
Renal Disease
257(1)
Definition
257(1)
Etiology
257(1)
Pathophysiology
257(1)
Epidemiology
257(1)
Diagnosis
257(1)
Prevention and Treatment
258(1)
Intensive Glycemic Management
259(3)
Definition
259(1)
Etiology/Rationale
259(1)
Outpatient Setting
259(1)
Type 1 DM
259(1)
Type 2 DM
260(1)
The Inpatient Setting
260(1)
Epidemiology
260(1)
Pathophysiology
260(2)
References
262(17)
7 Lipid Disorders
279(21)
Francis Q. Almeda
Susan DeLange
Lipoprotein Metabolism
279(2)
Low-Density Lipoprotein Cholesterol
281(7)
Trials
281(1)
Primary Prevention Trials
281(3)
Secondary Prevention Trials
284(1)
How Low Should You Go?
284(1)
Treatment Options
285(1)
Dietary Modification
285(1)
Statins (3-Hydroxy-3-Methylglutaryl Coenzyme A Reduetase Inhibitors)
285(1)
Statin Therapy in High-Risk Populations
285(2)
Ezetimibe (Zetia)
287(1)
Bile Acid Sequestrants (Resins)
288(1)
Nicotinic Acid and Fibric Acids
288(1)
Combination Therapy
288(1)
Nonpharmacologic Strategies
288(1)
High-Density Lipoprotein Cholesterol and Triglycerides
288(3)
Treatment Options
289(1)
Therapeutic Lifestyle Changes
289(1)
Nicotinic Acid (Niacin)
289(1)
Fibric Acids (Fibrates)
289(1)
Statins
290(1)
Fish Oils
290(1)
New Treatment Options for Increasing HDL
290(1)
Lipoprotein(A)
291(1)
Homocysteine
291(1)
Future Directions
291(1)
References
292(8)
8 Obesity and Nutrition
300(22)
Jeffrey I. Mechanick
Elise M. Brett
Definition
300(1)
Epidemiology
301(1)
Etiology
301(1)
Pathophysiology
302(1)
Treatment
302(5)
Therapeutic Lifestyle Changes
303(1)
Behavioral
303(1)
Healthy Eating and Nutrition
304(2)
Physical Activity
306(1)
Pharmacotherapy
307(1)
Orlistat
307(1)
Phentermine
307(1)
Diethylpropion
307(1)
History
307(1)
Future Directions
308(1)
Bariatric Surgery
308(1)
References
309(13)
9 Multiple Endocrine Neoplasia
322(26)
Glen Sizemore
Norma Lopes
Men Type 1
324(5)
Screening
324(1)
Enteropancreatic Disease
325(1)
Gastrin-Secreting Tumors
325(1)
Diagnosis
325(1)
Treatment
326(1)
Insulin-Secreting and Other Tumor Types
327(1)
Diagnosis
327(1)
Treatment
327(1)
Parathyroid Disease
327(1)
Diagnosis
327(1)
Treatment
328(1)
Pituitary Disease
328(1)
Associated Diseases
329(1)
Men Type 2
329(6)
Screening
329(1)
Medullary Thyroid Carcinoma
330(1)
Diagnosis
330(1)
Treatment
330(3)
Pheochromocytoma
333(1)
Diagnosis
333(1)
Treatment
334(1)
Parathyroid Disease
335(1)
Treatment
335(1)
Should Patients with Thyroid Nodules be Screened for MTC?
335(1)
References
336(12)
10 Carcinoid Tumors
348(7)
Nathan J. O'Dorisio
Thomas M. O'Dorisio
M. Sue O'Dorisio
Definition
348(1)
Etiology
348(1)
Epidemiology
349(1)
Pathology
349(1)
Diagnosis
350(1)
Biomarkers
350(1)
Treatment
351(1)
References
352(3)
11 Paraneoplastic Endocrine Syndromes
355(17)
Subhash Kukreja
Hypercalcemia of Malignancy
355(5)
Definition
355(1)
Etiology
356(1)
Epidemiology
357(1)
Pathophysiology
357(1)
Diagnosis
358(1)
Treatment
358(1)
Prognosis
359(1)
Antiresorptive Agents (Bisphosphonates and Denosumab) for Treatment of Bone Metastases
359(1)
Hypoealeemia
360(1)
Tumor-Induced Osteomalacia
360(1)
Ectopic Adrenocorticotropic Hormone Syndrome
361(2)
Non-Islet Cell Tumor-Induced Hypoglycemia
363(1)
Acromegaly
363(1)
Hyperthyroidism
364(1)
References
364(8)
12 Genetics
372(21)
Peter Kopp
Definition
372(5)
Etiology
377(1)
Epidemiology
378(1)
Pathophysiology
379(1)
Diagnosis
379(5)
Approach to the Patient
379(1)
Information about Genetic Disorders
380(1)
Genetic Counseling
380(1)
Genetic Testing
380(1)
Sample Collection
381(1)
Laboratories Performing Genetic Tests
381(1)
Practical Limitations of Genetic Testing
382(2)
Treatment
384(1)
Acknowledgments
384(1)
References
384(9)
Index 393